Plenary Session

397 Episoder

1. 5.06 - POLO trial now has OS results - OMG

   Publisert: 21.7.2022
2. 5.05 - Citations, Metrics, Rankings in Oncology & Medicine

   Publisert: 18.7.2022
3. 5.04 - Echelon 1 reports OS benefit - But does it add up?

   Publisert: 14.7.2022
4. 5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?

   Publisert: 13.7.2022
5. 5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers

   Publisert: 11.7.2022
6. 5.01 - How To Read Randomized Trials In Cancer

   Publisert: 7.7.2022
7. Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health

   Publisert: 22.6.2022
8. Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer

   Publisert: 20.6.2022
9. Kids Vaccine For Under 5 years Old

   Publisert: 18.6.2022
10. H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189

    Publisert: 18.6.2022
11. QuANTUM - Quizartinib Front Line - Ethics of Global Trials

    Publisert: 15.6.2022
12. 4.67 Teclistimab for R/R Multiple Myeloma

    Publisert: 9.6.2022
13. 4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??

    Publisert: 8.6.2022
14. 4.65 DESTINY BREAST 04 - A complex trial to deconstruct

    Publisert: 7.6.2022
15. 4.64 - DETERMINATION - Should we still use transplant Myeloma?

    Publisert: 6.6.2022
16. 4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer

    Publisert: 5.6.2022
17. 4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial

    Publisert: 4.6.2022
18. 4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis

    Publisert: 27.5.2022
19. 4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods

    Publisert: 21.5.2022
20. 4.59 - How to be a better reader of case control studies

    Publisert: 17.5.2022